Fariborz A. Yaghini

522 total citations
17 papers, 440 citations indexed

About

Fariborz A. Yaghini is a scholar working on Biochemistry, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Fariborz A. Yaghini has authored 17 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Biochemistry, 7 papers in Cardiology and Cardiovascular Medicine and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Fariborz A. Yaghini's work include Eicosanoids and Hypertension Pharmacology (11 papers), Hormonal Regulation and Hypertension (7 papers) and Renin-Angiotensin System Studies (6 papers). Fariborz A. Yaghini is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (11 papers), Hormonal Regulation and Hypertension (7 papers) and Renin-Angiotensin System Studies (6 papers). Fariborz A. Yaghini collaborates with scholars based in United States and Türkiye. Fariborz A. Yaghini's co-authors include Kafait U. Malik, Anne M. Estes, Chi Young Song, Xiao Fang, Brett L. Jennings, William B. Campbell, C. Kemal Buharalıoğlu, Eduard N. Lavrentyev, Seyhan Şahan-Fırat and Bahar Tunçtan and has published in prestigious journals such as Journal of Biological Chemistry, The FASEB Journal and Journal of Cell Science.

In The Last Decade

Fariborz A. Yaghini

17 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fariborz A. Yaghini United States 13 168 142 130 118 84 17 440
Noriko Aoi Japan 16 163 1.0× 247 1.7× 165 1.3× 187 1.6× 62 0.7× 39 628
Marlina Manhiani United States 11 226 1.3× 283 2.0× 146 1.1× 120 1.0× 107 1.3× 12 657
Chi Young Song United States 20 122 0.7× 161 1.1× 150 1.2× 280 2.4× 80 1.0× 37 810
Krairerk Athirakul United States 7 205 1.2× 95 0.7× 121 0.9× 141 1.2× 86 1.0× 15 467
K. Lockhart Jamieson Canada 15 335 2.0× 151 1.1× 127 1.0× 134 1.1× 75 0.9× 23 549
Kimberly M. Hoagland United States 13 234 1.4× 415 2.9× 187 1.4× 227 1.9× 148 1.8× 16 735
Steven M. Weldon United States 11 314 1.9× 239 1.7× 102 0.8× 198 1.7× 171 2.0× 19 641
Dany Salvail Canada 17 93 0.6× 99 0.7× 112 0.9× 147 1.2× 164 2.0× 26 672
Yaomin Du China 8 58 0.3× 81 0.6× 141 1.1× 133 1.1× 34 0.4× 8 421
Ugo Cavallari Italy 16 115 0.7× 189 1.3× 428 3.3× 191 1.6× 60 0.7× 30 967

Countries citing papers authored by Fariborz A. Yaghini

Since Specialization
Citations

This map shows the geographic impact of Fariborz A. Yaghini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fariborz A. Yaghini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fariborz A. Yaghini more than expected).

Fields of papers citing papers by Fariborz A. Yaghini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fariborz A. Yaghini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fariborz A. Yaghini. The network helps show where Fariborz A. Yaghini may publish in the future.

Co-authorship network of co-authors of Fariborz A. Yaghini

This figure shows the co-authorship network connecting the top 25 collaborators of Fariborz A. Yaghini. A scholar is included among the top collaborators of Fariborz A. Yaghini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fariborz A. Yaghini. Fariborz A. Yaghini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Jennings, Brett L., Michael May, Anne M. Estes, et al.. (2014). Cytochrome P450 1B1 contributes to increased blood pressure and cardiovascular and renal dysfunction in spontaneously hypertensive rats. Cardiovascular Drugs and Therapy. 28(2). 145–161. 28 indexed citations
3.
Jennings, Brett L., Anne M. Estes, Larry J. Anderson, et al.. (2012). Cytochrome P450 1B1 Gene Disruption Minimizes Deoxycorticosterone Acetate-Salt–Induced Hypertension and Associated Cardiac Dysfunction and Renal Damage in Mice. Hypertension. 60(6). 1510–1516. 23 indexed citations
4.
Malik, Kafait U., Brett L. Jennings, Fariborz A. Yaghini, et al.. (2011). Contribution of cytochrome P450 1B1 to hypertension and associated pathophysiology: A novel target for antihypertensive agents. Prostaglandins & Other Lipid Mediators. 98(3-4). 69–74. 35 indexed citations
5.
Jennings, Brett L., Larry J. Anderson, Anne M. Estes, et al.. (2011). Cytochrome P450 1B1 Contributes to Renal Dysfunction and Damage Caused by Angiotensin II in Mice. Hypertension. 59(2). 348–354. 43 indexed citations
6.
Buharalıoğlu, C. Kemal, Chi Young Song, Fariborz A. Yaghini, et al.. (2011). Angiotensin II-induced process of angiogenesis is mediated by spleen tyrosine kinase via VEGF receptor-1 phosphorylation. American Journal of Physiology-Heart and Circulatory Physiology. 301(3). H1043–H1055. 42 indexed citations
8.
Yaghini, Fariborz A., Chi Young Song, Eduard N. Lavrentyev, et al.. (2010). Angiotensin II–Induced Vascular Smooth Muscle Cell Migration and Growth Are Mediated by Cytochrome P450 1B1–Dependent Superoxide Generation. Hypertension. 55(6). 1461–1467. 73 indexed citations
9.
Şahan-Fırat, Seyhan, Brett L. Jennings, Fariborz A. Yaghini, et al.. (2010). 2,3′,4,5′-Tetramethoxystilbene prevents deoxycorticosterone-salt-induced hypertension: contribution of cytochrome P-450 1B1. American Journal of Physiology-Heart and Circulatory Physiology. 299(6). H1891–H1901. 35 indexed citations
11.
Tunçtan, Bahar, Fariborz A. Yaghini, Anne M. Estes, & Kafait U. Malik. (2008). Prostaglandins inhibit cytochrome P450 4A activity and contribute to endotoxin-induced hypotension in rats via nitric oxide production. Archives of Pharmacal Research. 31(7). 856–865. 14 indexed citations
13.
Yaghini, Fariborz A., Fang Li, & Kafait U. Malik. (2007). Expression and Mechanism of Spleen Tyrosine Kinase Activation by Angiotensin II and Its Implication in Protein Synthesis in Rat Vascular Smooth Muscle Cells. Journal of Biological Chemistry. 282(23). 16878–16890. 25 indexed citations
14.
Tunçtan, Bahar, Fariborz A. Yaghini, Anne M. Estes, & Kafait U. Malik. (2005). Inhibition by nitric oxide of cytochrome P450 4A activity contributes to endotoxin-induced hypotension in rats. Nitric Oxide. 14(1). 51–57. 18 indexed citations
15.
Fatima, Soghra, et al.. (2005). Intact Actin Filaments Are Required for Cytosolic Phospholipase A2 Translocation but Not for Its Activation by Norepinephrine in Vascular Smooth Muscle Cells. Journal of Pharmacology and Experimental Therapeutics. 313(3). 1017–1026. 10 indexed citations
16.
Yaghini, Fariborz A., et al.. (2005). Contribution of Arachidonic Acid Metabolites Derived Via Cytochrome P4504A to Angiotensin II–Induced Neointimal Growth. Hypertension. 45(6). 1182–1187. 23 indexed citations
17.
Fatima, Soghra, et al.. (2002). CaM kinase IIα mediates norepinephrine-induced translocation of cytosolic phospholipase A2 to the nuclear envelope. Journal of Cell Science. 116(2). 353–365. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026